The outcome of this study could significantly impact Sanofi’s stock performance and investor sentiment, as successful results may position Teplizumab as a leading treatment for Type 1 Diabetes. This ...

August 01, 2025 - The increasing prevalence of chronic and genetic diseases is a major factor driving revenue growth in the gene expression analysis ...